← Back to All US Stocks

Abpro Holdings, Inc. (ABPWW) Stock Fundamental Analysis & AI Rating 2026

ABPWW OTC Biological Products, (No Diagnostic Substances) DE CIK: 0001893219
Updated This Month • Analysis: Mar 19, 2026 • SEC Data: 2025-09-30
Combined AI Rating
STRONG SELL
96% Confidence
STRONG AGREEMENT
STRONG SELL
95% Conf
STRONG SELL
96% Conf

📊 ABPWW Key Takeaways

Revenue: $183.0K
Net Margin: -4,660.1%
Free Cash Flow: $-5.4M
Current Ratio: 0.07x
Debt/Equity: N/A
EPS: $-4.12
AI Rating: STRONG SELL with 95% confidence
Abpro Holdings, Inc. (ABPWW) receives a STRONG SELL rating with 96% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $183.0K, net profit margin of -4,660.1%, Abpro Holdings, Inc. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete ABPWW stock analysis for 2026.

Is Abpro Holdings, Inc. (ABPWW) a Good Investment?

Claude

Abpro Holdings exhibits severe financial distress with massive operating losses (-$6.6M on $183K revenue), negative stockholders equity of -$16.1M, and critical liquidity problems (0.07x current ratio). The company is burning cash at an unsustainable rate (-$5.4M operating cash flow) with minimal revenue generation and no clear path to profitability.

ChatGPT

Abpro Holdings shows extremely weak fundamentals, with minimal revenue relative to its cost base and deeply negative operating and net margins. Financial health appears distressed: cash is very low, free cash flow is strongly negative, the current ratio is far below 1.0x, and stockholders' equity is negative, indicating a highly fragile balance sheet. While revenue grew year over year, the growth quality is poor because it is far too small to offset ongoing losses and cash burn.

Why Buy Abpro Holdings, Inc. Stock? ABPWW Key Strengths

Claude
  • + Revenue growth of 50% YoY demonstrates some commercial traction
  • + Maintains $328K in cash reserves providing short-term runway
  • + No insider selling activity in past 90 days suggests management confidence
ChatGPT
  • + Revenue increased 50.0% year over year, indicating some top-line progress
  • + Asset-light structure may limit capital expenditure needs
  • + Reported revenue shows the business is not purely pre-revenue

ABPWW Stock Risks: Abpro Holdings, Inc. Investment Risks

Claude
  • ! Negative stockholders equity of -$16.1M indicates balance sheet insolvency
  • ! Operating margin of -3582% reflects inability to scale operations profitably
  • ! Negative free cash flow of -$5.4M unsustainable; company will deplete cash within months at current burn rate
  • ! Total liabilities ($19.6M) exceed total assets ($1.7M) by 11.5x
  • ! Current ratio of 0.07x indicates severe liquidity crisis and inability to meet short-term obligations
  • ! Net margin of -4660% shows every dollar of revenue generates $46.60 in losses
ChatGPT
  • ! Severe profitability issues, with operating margin of -3582.0% and net margin of -4660.1%
  • ! Liquidity stress is acute, with only $328.00K in cash and a 0.07x current ratio
  • ! Negative stockholders' equity of -$16.14M indicates balance sheet impairment and elevated financing risk

Key Metrics to Watch

Claude
  • * Cash burn rate and months of runway remaining
  • * Gross margin achievement when higher revenue volumes reached
  • * Path to operating cash flow breakeven
  • * Stockholders equity recovery trajectory
  • * Revenue growth sustainability
ChatGPT
  • * Quarterly cash burn versus cash balance
  • * Revenue growth relative to operating loss reduction

Abpro Holdings, Inc. (ABPWW) Financial Metrics & Key Ratios

Revenue
$183.0K
Net Income
$-8.5M
EPS (Diluted)
$-4.12
Free Cash Flow
$-5.4M
Total Assets
$1.7M
Cash Position
$328.0K

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

ABPWW Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin -3,582.0%
Net Margin -4,660.1%
ROE N/A
ROA -500.8%
FCF Margin -2,969.4%

ABPWW vs Healthcare Sector: How Abpro Holdings, Inc. Compares

How Abpro Holdings, Inc. compares to Healthcare sector averages

Net Margin
ABPWW -4,660.1%
vs
Sector Avg 12.0%
ABPWW Sector
ROE
ABPWW 0.0%
vs
Sector Avg 15.0%
ABPWW Sector
Current Ratio
ABPWW 0.1x
vs
Sector Avg 2.0x
ABPWW Sector
Debt/Equity
ABPWW 0.0x
vs
Sector Avg 0.6x
ABPWW Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Abpro Holdings, Inc. Stock Overvalued? ABPWW Valuation Analysis 2026

Based on fundamental analysis, Abpro Holdings, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
-4,660.1%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Abpro Holdings, Inc. Balance Sheet: ABPWW Debt, Cash & Liquidity

Current Ratio
0.07x
Quick Ratio
0.07x
Debt/Equity
N/A
Debt/Assets
1,151.3%
Interest Coverage
N/A
Long-term Debt
N/A

ABPWW Revenue & Earnings Growth: 5-Year Financial Trend

ABPWW 5-year financial data: Year 2024: Revenue $183.0K, Net Income N/A, EPS $-0.61.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Abpro Holdings, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-22.31 indicates the company is currently unprofitable.

ABPWW Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-2,969.4%
Free cash flow / Revenue

Abpro Holdings, Inc. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$5.4M
Cash generated from operations
Stock Buybacks
$29.7M
Shares repurchased (TTM)
Capital Expenditures
$48.0K
Investment in assets
Dividends
None
No dividend program

ABPWW SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Abpro Holdings, Inc. (CIK: 0001893219)

📋 Recent SEC Filings

Date Form Document Action
Apr 15, 2026 10-K ea0286397-10k_abpro.htm View →
Feb 20, 2026 8-K ea0277804-8k_abpro.htm View →
Feb 11, 2026 8-K ea0276604-8k_abpro.htm View →
Feb 3, 2026 8-K ea0275295-8k_abpro.htm View →
Jan 23, 2026 8-K ea0273734-8k_abpro.htm View →

Frequently Asked Questions about ABPWW

What is the AI rating for ABPWW?

Abpro Holdings, Inc. (ABPWW) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 96% combined confidence, based on fundamental analysis of SEC EDGAR filings.

What are ABPWW's key strengths?

Claude: Revenue growth of 50% YoY demonstrates some commercial traction. Maintains $328K in cash reserves providing short-term runway. ChatGPT: Revenue increased 50.0% year over year, indicating some top-line progress. Asset-light structure may limit capital expenditure needs.

What are the risks of investing in ABPWW?

Claude: Negative stockholders equity of -$16.1M indicates balance sheet insolvency. Operating margin of -3582% reflects inability to scale operations profitably. ChatGPT: Severe profitability issues, with operating margin of -3582.0% and net margin of -4660.1%. Liquidity stress is acute, with only $328.00K in cash and a 0.07x current ratio.

What is ABPWW's revenue and growth?

Abpro Holdings, Inc. reported revenue of $183.0K.

Does ABPWW pay dividends?

Abpro Holdings, Inc. does not currently pay dividends.

Where can I find ABPWW SEC filings?

Official SEC filings for Abpro Holdings, Inc. (CIK: 0001893219) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is ABPWW's EPS?

Abpro Holdings, Inc. has a diluted EPS of $-4.12.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is ABPWW a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Abpro Holdings, Inc. has a STRONG SELL rating with 96% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is ABPWW stock overvalued or undervalued?

Valuation metrics for ABPWW: ROE of N/A (sector avg: 15%), net margin of -4,660.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy ABPWW stock in 2026?

Our dual AI analysis gives Abpro Holdings, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is ABPWW's free cash flow?

Abpro Holdings, Inc.'s operating cash flow is $-5.4M, with capital expenditures of $48.0K. FCF margin is -2,969.4%.

How does ABPWW compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -4,660.1% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.07 (avg: 2).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 19, 2026 | Data as of: 2025-09-30 | Powered by Claude AI